PETVIVO HOLDINGS, INC. ANNOUNCES PARTICIPATION AT THE H.C. Wainwright Global Investment Conference May 23-26, 2022
May 17, 2022 07:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, May 17, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative...
PETVIVO HOLDINGS, INC. TO EXHIBIT AT VETERINARY MEETING AND EXPO CONFERENCE IN ORLANDO, FLORIDA
January 10, 2022 07:45 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Jan. 10, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
PetVivo Reports Second Quarter 2022 Financial Results
November 15, 2021 15:00 ET
|
PetVivo Holdings, Inc.
Raised approximately 11.25 million in connection with Initial Public Offering Rebranded Kush™ as Spryng™ and commenced sales of Spryng™ Conference call begins at 4:00 p.m. Central time...
PETVIVO HOLDINGS, INC. TO ANNOUNCE SECOND QUARTER 2022 RESULTS
November 11, 2021 16:30 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Nov. 11, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (“PetVivo”), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics...